Want to see SIGA full AI Analyst Report?
SIGA Stock Chart & Stats
$3.11
$0.04(1.29%)
At close: 4:00 PM EDT
$3.11
$0.04(1.29%)
Day’s Range― - ―
52-Week Range$3.01 - $9.62
Previous CloseN/A
Volume53.73K
Average Volume (3M)461.52K
Market Cap
$233.10M
Enterprise Value$238.40
Total Cash (Recent Filing)$145.56M
Total Debt (Recent Filing)$638.23K
Price to Earnings (P/E)11.4
Beta1.58
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding71,724,100
10 Day Avg. Volume376,632
30 Day Avg. Volume461,516
Financial Highlights & Ratios
PEG Ratio-0.31
Price to Book (P/B)2.20
Price to Sales (P/S)4.62
P/FCF Ratio10.15
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.7
Revenue Forecast (FY)$66.31M
Bulls Say, Bears Say
Bulls Say
Strong Liquidity And Zero Net DebtA large cash balance with no debt provides durable financial flexibility: funds R&D and regulatory work, underpins multi-year runway despite lumpy orders, enables opportunistic M&A or commercial investment, and supports repeated special dividends without stressing operations.
Near-term Government And International Order VisibilityConfirmed sizable orders from governments and the SNS provide recurring strategic demand and revenue pillars. Government procurement relationships and awarded deliveries create structural revenue anchors that mitigate commercial market volatility and support planning across multiple quarters.
Advancing Pipeline: Pediatric And PEP ProgramsProgress on pediatric IND, Phase 1 study, and PEP regulatory pathway represents structural diversification beyond stockpile sales. New indications would broaden addressable markets, create recurring clinical and commercial pathways, and reduce reliance on episodic procurement over the medium term.
Bears Say
Sharp Recent Revenue Decline And Concentration RiskMaterial revenue contraction highlights dependence on episodic government orders and a concentrated customer base. Prolonged or repeated revenue declines would compress operating leverage, weaken pricing power in negotiations, and reduce predictability of cash flows needed to sustain R&D and commercialization investments.
Outsized TTM Net Loss And Earnings VolatilityA large trailing net loss despite historical margins undermines earnings quality and forecasting. Persistent volatility complicates budgeting for manufacturing scale, R&D timelines, and contract bidding, and may pressure management to prioritize cash preservation over long-term growth initiatives.
Regulatory Setback In Europe (MPOXX Withdrawal Recommendation)A CHMP recommendation to withdraw an indication creates structural uncertainty for European commercialization and may reduce market access or complicate label strategy. Regulatory actions can delay launches, increase compliance costs, and limit revenue diversification across regions over multiple quarters.
SIGA Technologies News
SIGA FAQ
What was SIGA Technologies Inc’s price range in the past 12 months?
SIGA Technologies Inc lowest stock price was $3.01 and its highest was $9.62 in the past 12 months.
What is SIGA Technologies Inc’s market cap?
SIGA Technologies Inc’s market cap is $233.10M.
When is SIGA Technologies Inc’s upcoming earnings report date?
SIGA Technologies Inc’s upcoming earnings report date is Aug 06, 2026 which is in 4 days.
How were SIGA Technologies Inc’s earnings last quarter?
SIGA Technologies Inc released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is SIGA Technologies Inc overvalued?
According to Wall Street analysts SIGA Technologies Inc’s price is currently Overvalued.
Does SIGA Technologies Inc pay dividends?
SIGA Technologies Inc pays a Notavailable dividend of $0.6 which represents an annual dividend yield of N/A. See more information on SIGA Technologies Inc dividends here
What is SIGA Technologies Inc’s EPS estimate?
SIGA Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SIGA Technologies Inc have?
SIGA Technologies Inc has 71,724,100 shares outstanding.
What happened to SIGA Technologies Inc’s price movement after its last earnings report?
SIGA Technologies Inc reported an EPS of -$0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.48%.
Which hedge fund is a major shareholder of SIGA Technologies Inc?
Currently, no hedge funds are holding shares in SIGA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SIGA Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
SIGA Sentiment 100%
Sector Average 65%
Sector Average 65%
Hedge Fund Trend
Increased
By 132.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.0%
Last 30 Days ▲ 13.0%
Last 30 Days ▲ 13.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-11.20%
Trailing 12-Months
Company Description
SIGA Technologies Inc
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
SIGA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally positive strategic and financial position driven by a strong cash balance, shareholder-friendly capital return, confirmed near-term international orders, regional commercial expansion via an exclusive Hikma agreement, and concrete pipeline progress (pediatric IND and PEP pathway). Offsetting these positives are the quarter's minimal deliveries and lumpy revenue profile, a small quarterly loss, a CHMP recommendation to withdraw the MPOXX indication in Europe, and slower progress toward a new U.S. government contract. Overall, the positives (liquidity, contracts, partnerships, and pipeline momentum) outweigh the near-term operational and regulatory headwinds.View all SIGA earnings summariesTechnical Analysis
Ownership Overview
1.75% Insiders
12.31% Mutual Funds
0.37% Other Institutional Investors
74.15% Public Companies and
Individual Investors